LNA Santé SA (EPA:LNA)
France · Delayed Price · Currency is EUR 24.70
-2.40 (-8.86%)
Oct 2, 2026, 5:35 PM CET
LNA Santé Ratios and Metrics
Market cap in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 2, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 254 | 251 | 246 | 206 | 311 | 484 | |
Market Cap Growth | -3.57% | 2.02% | 19.88% | -33.91% | -35.78% | 2.77% |
Enterprise Value | 1,115 | 1,096 | 1,056 | 1,044 | 1,150 | 1,364 |
Last Close Price | 24.70 | 23.86 | 22.89 | 18.63 | 26.95 | 45.21 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 2, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 10.02 | 10.41 | 11.30 | 8.78 | 12.05 | 20.60 |
Forward PE | 8.30 | 9.06 | 9.40 | 7.39 | 9.98 | 15.16 |
PS Ratio | 0.27 | 0.28 | 0.31 | 0.28 | 0.43 | 0.70 |
PB Ratio | 0.74 | 0.74 | 0.76 | 0.67 | 1.04 | 2.17 |
P/FCF Ratio | 2.87 | 2.85 | 2.47 | 2.39 | 3.41 | 6.95 |
P/OCF Ratio | 2.58 | 2.53 | 2.23 | 2.11 | 3.01 | 6.06 |
PEG Ratio | - | 0.22 | 0.22 | 0.22 | 0.22 | 0.25 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 2, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 1.17 | 1.20 | 1.31 | 1.42 | 1.58 | 1.98 |
EV/EBITDA Ratio | 6.96 | 11.46 | 11.52 | 12.47 | 15.13 | 16.28 |
EV/EBIT Ratio | 14.67 | 15.03 | 16.76 | 16.91 | 23.51 | 23.21 |
EV/FCF Ratio | 12.57 | 12.41 | 10.60 | 12.15 | 12.60 | 19.58 |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 2, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 2.74 | 2.66 | 2.71 | 2.88 | 3.05 | 4.51 |
Debt / EBITDA Ratio | 5.90 | 5.84 | 5.77 | 6.24 | 6.84 | 7.19 |
Debt / FCF Ratio | 10.61 | 10.28 | 8.80 | 10.33 | 9.99 | 14.44 |
Net Debt / Equity Ratio | 2.48 | 2.38 | 2.48 | 2.63 | 2.71 | 3.83 |
Net Debt / EBITDA Ratio | 8.57 | 8.50 | 8.75 | 9.68 | 10.65 | 10.20 |
Net Debt / FCF Ratio | 9.60 | 9.20 | 8.04 | 9.43 | 8.87 | 12.26 |
Asset Turnover | 0.59 | 0.58 | 0.53 | 0.49 | 0.48 | 0.46 |
Inventory Turnover | 3.39 | 3.51 | 3.37 | 4.01 | 5.43 | 5.35 |
Quick Ratio | 0.44 | 0.48 | 0.46 | 0.51 | 0.43 | 0.48 |
Current Ratio | 0.87 | 0.91 | 0.91 | 0.94 | 0.64 | 0.65 |
Return on Equity (ROE) | 8.04% | 7.73% | 7.25% | 7.98% | 10.86% | 11.45% |
Return on Assets (ROA) | 2.91% | 2.90% | 2.59% | 2.56% | 2.01% | 2.43% |
Return on Invested Capital (ROIC) | 4.06% | 4.14% | 3.79% | 3.61% | 2.86% | 3.44% |
Return on Capital Employed (ROCE) | 6.60% | 6.40% | 5.60% | 5.40% | 4.80% | 6.00% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 2, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | 9.96% | 9.60% | 8.85% | 11.39% | 8.30% | 4.85% |
FCF Yield | 34.86% | 35.12% | 40.43% | 41.83% | 29.33% | 14.39% |
Dividend Yield | 3.85% | 3.98% | 2.84% | 3.22% | 1.85% | 0.95% |
Payout Ratio | 26.33% | 27.63% | 28.13% | 21.84% | 17.51% | 8.15% |
Buyback Yield / Dilution | -0.33% | -0.33% | -0.03% | 1.32% | -7.93% | -0.17% |
Total Shareholder Return | 3.52% | 3.65% | 2.81% | 4.54% | -6.07% | 0.78% |